188宝金博页面版

  • 图案背景
  • 纯色背景
视图
标记
批注
批注本地保存成功,开通会员云端永久保存 去开通
doctudou

上传于:2015-11-07

粉丝量:15

该文档贡献者很忙,什么也没留下。


  • 相关
  • 目录
  • 笔记
  • 书签

188宝金博页面版:更多相关文档

  • Michelle Kwan helps provide magical first g - 香港迪firstFIRSTfirstFIRSTfirstFIRSTfirstFIRSTfirstFIRSTfirstFIRSTfirstFIRSTfirstF

    星级: 2 页

  • First Set - First()

    星级: 1 页

  • (first-in-first-out)

    星级: 17 页

  • (first-come-first

    星级: 3 页

  • first-come-first

    星级: 2 页

  • 小心别用混first及at first

    星级: 4 页

  • First_Thing_First

    星级: 50 页

  • first-come-first-in

    星级: 3 页

  • First Steps First

    星级: 8 页

  • _First Things First

    星级: 64 页

  • Who’s Who at FIRST - FIRST

    星级: 80 页

暂无目录

点击鼠标右键菜单,创建目录

暂无笔记

选择文本,点击鼠标右键菜单,添加笔记

暂无书签

在左侧文档中,点击鼠标右键,添加书签

188宝金博页面版: First reports of serious adverse drug reactions in recent weeks

下载积分: 4990

内容提示: DRUG REACTIONS AND INTERACTIONSFirst reports of serious adverse drug reactions in recent weeksPublished online: 21 August 2013? Springer International Publishing Switzerland 2013The following table contains an overview of first publishedcase reports of serious adverse drug reactions identified inthe international literature in recent weeks by the drugsafety alerting service Reactions Weekly. An event isserious (US FDA MedWatch definition) when the patientoutcome is death, life threatening, hospitalization,...

文档格式:PDF | 页数:1 | 浏览次数:13 | 上传日期:2015-11-07 10:15:30 | 文档星级:
DRUG REACTIONS AND INTERACTIONSFirst reports of serious adverse drug reactions in recent weeksPublished online: 21 August 2013? Springer International Publishing Switzerland 2013The following table contains an overview of first publishedcase reports of serious adverse drug reactions identified inthe international literature in recent weeks by the drugsafety alerting service Reactions Weekly. An event isserious (US FDA MedWatch definition) when the patientoutcome is death, life threatening, hospitalization, disabil-ity, congenital anomaly or requires intervention to preventpermanent impairment or damage. Reactions and thecustomized Reactions Pharmacovigilance Service areproduced by Adis, and monitor[4000 journals, includingrelevant MEDLINE- and EMBASE-indexed journals, aswell as companion journal supplements, major scientificmeetings, the newsletters from the [80 national centresparticipating in the WHO International Drug MonitoringProgramme, media releases, pharmaceutical companywebsites, and regulatory agency websites.Drug and serious adverse reactionReferenceAceclofenac: acute tubulointerstitial nephritisGupta M, Cruz SD, Nada R, et al. Aceclofenac-induced acute tubulointerstitialnephritis in a patient with diabetes. BMJ Case Rep. 2013; pii:bcr2013009217.Agomelatine: deliriumViejo Sacha MG, De Ambrosi B, Mun˜oz C, et al. Two cases of delirium withagomelatine therapy. Ann Clin Psychiatry. 2013;25(1):67–8.Baclofen: increased blood triglyceride levelsClarisse H, Imbert B, Belzeaux R, et al. Baclofen and risperidone associationincreases dramatically triglycerides level. Alcohol Alcohol. 2013;48(4):515–6.Ceftaroline fosamil: agranulocytosis in an elderly patientRimawi RH, Frenkel A, Cook PP. Ceftaroline: a cause for neutropenia. J ClinPharm Ther. 2013;38(4):330–2.Colistin: contact tracheobronchitisVogel S, Varga R, Friedl T, et al. Respiratory insufficiency due to contact allergyto colistin [abstract no. 808]. Allergy. 2012;67 Suppl S96:313-4.Insulin detemir: interactions with amoxicillin, clarithromycin andomeprazole leading to hypoglycaemia in an elderly patientOtsuka SH. Severe hypoglycemia from Helicobacter pylori triple-drug therapyand insulin detemir drug interaction. Pharmacotherapy. 2013;33(4):e45–9.Linagliptin/vildagliptin: hepatitis in an elderly patientDanish Health and Medicines Authority. Acute pancreatitis and hepatitisassociated with the use of vildagliptin (Galvus?) and linagliptin (Trajenta?)reported as potential adverse reactions. Dan Pharmacovig Update. 2013;4(6):5.Phenylephrine: type IV reaction manifesting as drughypersensitivity syndromeRice SA, Swale VJ, Haque R, et al. Erythroderma in the emergency department.BMJ. 2013;346:f3613.Tocilizumab: hepatitisAlfreijat M, Habibi M, Bhatia P, et al. Severe hepatitis associated withtocilizumab in a patient with rheumatoid arthritis. Rheumatology (Oxford).2013;52(7):1340–1.Tocilizumab: mesangial proliferative glomerulonephritisMatsuo Y, Mizoguchi F, Kohsaka H, et al. Tocilizumab-induced immunecomplex glomerulonephritis in a patient with rheumatoid arthritis.Rheumatology (Oxford). 2013;52(7):1341–3.Valproate: panhypogammaglobulinaemia in an infantEom TH, Lee HS, Jang PS, et al. Valproate-inducedpanhypogammaglobulinemia. Neurol Sci. 2013;34(6):1003–4.Vemurafenib: pancreatitisMuluneh B, Buie LW, Collichio F. Vemurafenib-associated pancreatitis: casereport. Pharmacotherapy. 2013;33(4):e43–4.Drugs Ther Perspect (2013) 29:320DOI 10.1007/s40267-013-0070-8

188宝金博页面版:关注我们

  • 新浪微博

关注188宝金博页面版公众号

188宝金博页面版
阅读
APP
阅读
返回
顶部
188宝金博页面版官网登录在线平台入口(2026已更新)—江苏协昌电子科技股份有限公司